Literature DB >> 19386345

Expression patterns of Trk-A, Trk-B, GRP78, and p75NRT in olfactory neuroblastoma.

Ilan Weinreb1, David Goldstein, Jonathan Irish, Bayardo Perez-Ordonez.   

Abstract

Olfactory neuroblastoma is an uncommon neuroectodermal tumor of the sinonasal tract. It represents 2% to 3% of sinonasal neoplasms. Most olfactory neuroblastoma behave locally aggressive with 30% recurrence rates. A subset metastasizes to lymph nodes and/or distant sites. Grading of olfactory neuroblastoma involves a combination of factors with low-grade tumors having better survival than high-grade tumors. The grade does not always predict prognosis, however, as metastases can be seen in all grades of olfactory neuroblastoma. Trk-A, Trk-B, and p75NRT are neurotrophin receptors associated with numerous solid malignancies, particularly pediatric neuroblastoma. GRP78 is an endoplasmic reticulum protein, associated with differentiation of neuroblastic cells. Trk-A, p75NRT, and GRP78 overexpression are favorable prognostic factors in pediatric neuroblastoma, whereas Trk-B is associated with a poorer prognosis in these tumors. Olfactory neuroblastoma is clinically distinct from pediatric neuroblastoma but shares some histological features. Trk-A and p75NRT have been demonstrated in olfactory neuroblastoma previously. Trk-B and GRP78 have not been investigated in olfactory neuroblastoma. None of these markers have been correlated with grade or outcome in olfactory neuroblastoma. To investigate the role of Trk-A, Trk-B, p75NRT, and GRP78, a series of 20 olfactory neuroblastomas was stained with these antibodies. Trk-A and Trk-B stained most cases of olfactory neuroblastoma (90% and 85%). GRP78 stained most cases (90%), although weakly. P75NRT demonstrated focal membranous staining in a sustentacular pattern (60%). None of these markers correlated with Hyams grade. None of these markers definitively correlated with patient outcome. Neurotrophin receptors do not appear to have a prognostic role; however, Trk's may play an oncogenic role in olfactory neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386345     DOI: 10.1016/j.humpath.2009.02.001

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

Review 1.  Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis.

Authors:  Khodayar Goshtasbi; Arash Abiri; Mehdi Abouzari; Ronald Sahyouni; Beverly Y Wang; Bobby A Tajudeen; Frank P K Hsu; Gilbert Cadena; Edward C Kuan
Journal:  Int Forum Allergy Rhinol       Date:  2019-06-28       Impact factor: 3.858

Review 2.  Endoplasmic reticulum chaperone glucose-regulated protein 78 in gastric cancer: An emerging biomarker.

Authors:  Yan Wang; Jian-Hong Wang; Xun-Lei Zhang; Xiao-Li Wang; Lei Yang
Journal:  Oncol Lett       Date:  2018-02-26       Impact factor: 2.967

Review 3.  Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.

Authors:  Huy Gia Vuong; Tam N M Ngo; Ian F Dunn
Journal:  J Neurooncol       Date:  2021-03-26       Impact factor: 4.130

4.  Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.

Authors:  Glen J Weiss; Winnie S Liang; Tyler Izatt; Shilpi Arora; Irene Cherni; Robert N Raju; Galen Hostetter; Ahmet Kurdoglu; Alexis Christoforides; Shripad Sinari; Angela S Baker; Raghu Metpally; Waibhav D Tembe; Lori Phillips; Daniel D Von Hoff; David W Craig; John D Carpten
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

5.  Dramatic response to targeted therapy in an aggressive olfactory neuroblastoma: illustrative case.

Authors:  Saksham Gupta; Wenya Linda Bi; Donald J Annino; Ian F Dunn
Journal:  J Neurosurg Case Lessons       Date:  2022-06-13

6.  Sam68 is a novel marker for aggressive neuroblastoma.

Authors:  Xiaohong Zhao; Zuoqing Li; Benfu He; Juncheng Liu; Suisheng Li; Li Zhou; Cuiling Pan; Zhe Yu; Zhe Xu
Journal:  Onco Targets Ther       Date:  2013-12-02       Impact factor: 4.147

Review 7.  Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.

Authors:  Piotr Czapiewski; Michał Kunc; Johannes Haybaeck
Journal:  Oncotarget       Date:  2016-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.